Skip to main content

Jury Sides 3M in the First Bair Hugger Bellwether Trial

Jury Sides 3M in the First Bair Hugger Bellwether Trial

Jury Sides 3M in the First Bair Hugger Bellwether Trial

Introduction

The two-week trial for 3M Bair Hugger System ended in favor of the defendant as the Minneapolis federal jury announced on May 30 that the plaintiff failed to provide adequate evidence to affirm the Bair Hugger System caused the surgical site infection. This was the first bellwether trial in a series of lawsuits lined up against the air warming blanket maker.

The plaintiff from South Carolina suffered a deep joint infection in 2010 after he underwent a total right knee replacement surgery during which the 3M Bair Hugger warming blanket was used. In the allegation, the plaintiff states that the defective design of the warming blanket was the reason for him to undergo the antibiotic treatments, intravenous injections, and revision surgery for the removal of his knee implant. A second 3M Bair Hugger System trial is expected to be trial-ready by December 2018, involving claims by a couple of Idaho.

More than 4,467 hip and knee infection lawsuits are filed against the Bair Hugger warming blanket maker. Similar cases are consolidated into multidistrict litigation (MDL) in the District of Minnesota before U.S. District Judge Joan Ericksen.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!